StockNews.com downgraded shares of Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Rating) from a hold rating to a sell rating in a research note released on Thursday. Several other analysts have also recently commented on MDGL. Canaccord Genuity Group boosted their price target on Madrigal Pharmaceuticals from $296.00 to $336.00 and gave the stock a buy rating […]
StockNews.com cut shares of Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Rating) from a hold rating to a sell rating in a research report released on Monday morning. MDGL has been the subject of several other research reports. Oppenheimer upped their price objective on Madrigal Pharmaceuticals from $300.00 to $350.00 in a report on Tuesday, May 16th. […]
Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Rating) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Monday. A number of other research firms also recently commented on MDGL. Oppenheimer increased their price objective on Madrigal Pharmaceuticals from $300.00 to […]
StockNews.com cut shares of Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Rating) from a hold rating to a sell rating in a research note issued to investors on Monday morning. Several other analysts have also recently commented on the company. Oppenheimer upped their target price on Madrigal Pharmaceuticals from $300.00 to $350.00 in a report on Tuesday, […]
StockNews.com upgraded shares of Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Rating) from a sell rating to a hold rating in a report released on Sunday morning. A number of other equities research analysts also recently weighed in on the company. Oppenheimer upped their target price on Madrigal Pharmaceuticals from $300.00 to $350.00 in a research report […]